Eugene St.Clair, MD

Duke University Medical Center
Durham, NC, United States

Dr. St.Clair is a member of the Division of Rheumatology and Immunology at Duke University Medical Center where he is the W. Lester Brooks, Jr. Professor of Medicine.

Dr. St.Clair’s primary research interests include the development of novel immunological therapies for Sjögren’s syndrome, rheumatoid arthritis, and systemic vasculitis. Dr. St.Clair serves as the Co-Director of the Immune Tolerance Network, a NIAID-funded consortium dedicated to the development of tolerance-inducing therapies in transplantation, allergy and asthma, and autoimmunity. He also has an active clinical practice at Duke.

Dr. St.Clair has authored over 200 peer-reviewed articles, book chapters, and reviews, and served as the lead editor for “Rheumatoid Arthritis,” a book describing the epidemiology, clinical features, pathogenesis, and treatment of this disease. He is a member of the American College of Rheumatology, American College of Physicians, American Medical Association, and the American Association of Immunologists. Dr. St.Clair previously served as a Deputy Editor for Arthritis and Rheumatism.

He is formerly the President of the Rheumatology Research Foundation and the President of the American College of Rheumatology.

Presentation(s):

• 1636: Dazodalibep, a CD40L Antagonist, in Subjects with Sjögren’s Having Moderate-to-Severe Systemic Disease Activity: Full Crossover Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study

  Monday, November 13, 2023
  2:45 PM – 2:55 PM PT

  Disclosure information not submitted.

• L10: Dazodalibep, a CD40L Antagonist, in a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial of Subjects with Sjögren’s Disease Having Unacceptable Symptomatic Burden but Limited Extraglandular Organ Involvement

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.